Hélène Cavé mostly deals with Internal medicine, Minimal residual disease, Genetics, Leukemia and Acute lymphocytic leukemia. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology and Oncology. The study incorporates disciplines such as Gene rearrangement, Clinical trial and Prospective cohort study in addition to Minimal residual disease.
Her work on Genetics is being expanded to include thematically relevant topics such as Cancer research. Her research in Leukemia intersects with topics in Myeloid leukemia and BCL11B. Her Acute lymphocytic leukemia research integrates issues from Molecular biology, Childhood Acute Lymphoblastic Leukemia, Fusion gene and Cumulative incidence.
Hélène Cavé mainly investigates Internal medicine, Cancer research, Genetics, Noonan syndrome and Leukemia. She does research in Internal medicine, focusing on Minimal residual disease specifically. Hélène Cavé interconnects Clinical trial, B cell, Childhood Acute Lymphoblastic Leukemia, Immunophenotyping and Acute lymphocytic leukemia in the investigation of issues within Minimal residual disease.
The concepts of her Cancer research study are interwoven with issues in Mutation, Frameshift mutation, Neuroblastoma RAS viral oncogene homolog, Tumor suppressor gene and Juvenile myelomonocytic leukemia. Her Noonan syndrome study also includes fields such as
Hélène Cavé spends much of her time researching Internal medicine, Noonan syndrome, Leukemia, Pediatrics and Cancer research. Hélène Cavé combines subjects such as Gastroenterology, Endocrinology and Oncology with her study of Internal medicine. Her work deals with themes such as Phenotype, Costello syndrome, MAPK/ERK pathway and PTPN11, which intersect with Noonan syndrome.
She is interested in Minimal residual disease, which is a field of Leukemia. Her Pediatrics study also includes
Her primary areas of study are Internal medicine, Leukemia, Noonan syndrome, Genetics and Minimal residual disease. Her Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology. Her Leukemia study deals with the bigger picture of Immunology.
Her study focuses on the intersection of Immunology and fields such as Stem cell with connections in the field of Cancer research and RNA-binding protein. Her Noonan syndrome research includes elements of Endocrinology, Sudden death, KRAS, PTPN11 and MAPK/ERK pathway. Her research integrates issues of Clinical trial, Survival rate, Imatinib, Survival analysis and Transplantation in her study of Minimal residual disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
J Gabert;E Beillard;V H J van der Velden;W Bi.
Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
Cavé H;van der Werff ten Bosch J;Suciu S;Guidal C.
The New England Journal of Medicine (1998)
Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus
Andrey P. Babenko;Michel Polak;Hélène Cavé;Kanetee Busiah.
The New England Journal of Medicine (2006)
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.
V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock.
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Tetsuya Niihori;Yoko Aoki;Yoko Narumi;Giovanni Neri.
Nature Genetics (2006)
The MLL recombinome of acute leukemias in 2013
C. Meyer;J. Hofmann;T. Burmeister;D. Gröger.
New insights to the MLL recombinome of acute leukemias
C. Meyer;E. Kowarz;J. Hofmann;A. Renneville.
The MLL recombinome of acute leukemias in 2017
C Meyer;T Burmeister;D Gröger;G Tsaur.
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
Elisabetta Flex;Valentina Petrangeli;Lorenzo Stella;Sabina Chiaretti.
Journal of Experimental Medicine (2008)
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
M. Bruggemann;A. Schrauder;T. Raff;H. Pfeifer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: